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Background
Transposon systems mediate stable integration of exo-
genous DNA elements into a host cell genome, and
have been successfully used in mammalian cells for the
generation of stable cell lines. The piggyBac (PB) trans-
poson system has been shown to have several advan-
tages over the other transposon system available [1-3]. It
has also been shown to generate stable cell lines at sig-
nificantly higher frequency than the conventional trans-
fections [3]. Here, we investigated the efficiency of the
piggyBac (PB) transposon to facilitate the co-expression
of multiple artificial transposons, each bearing a single
transgene and the puromycin resistance gene for selec-
tion. Green fluorescent protein (eGFP), red fluorescent
protein (mKate), and a human IgG1 antibody were used
as model proteins [4]. The effect of the stringency of
selection on pool productivity was determined with
increasing concentrations of puromycin. The duration of
selection necessary for the generation of recombinant
cell pools was also tested by selecting for a period of
either 5 or 10 days.
Materials and methods
CHO-DG44 transfection
Cells were transfected using linear 25 kDa polyethyleni-
mine (PEI) (Polysciences, Eppenheim, Germany). All the
transfections are done in a final volume of 10 mL. Trans-
fected cultures were incubated at 37°C in 5% CO2 and
85% humidity with agitation at 180 rpm. The ratio of
plasmid coding for Gene of Interest (GOI) to the plasmid
coding for the transposase was kept constant at 9:1.
Generation of pools and clones
For the generation of stable pools, two days post trans-
fection the cells were seeded at a density of 5 x 10
5
cells/mL in ProCHO5 and puromycin. The cells were
placed under selection pressure for 5 or 10 days. In case
of a 10 day selection period, the puromycin concentra-
tion in the cultures was replenished on day 7 post trans-
fection by seeding at a density of 5 x10
5 cells/mL in
fresh ProCHO5 with puromycin. For productivity analy-
sis the cells were seeded at a density of 3 x10
5 cells/mL
and analyzed at day four.
Stable clones were generated by limiting dilution of
the pools. The productivity of the clones was analyzed
after five days of culture.
Analyses
A Guava EasyCyte microcapillary flow cytometer (Milli-
pore) with excitation and emission wavelengths of 488
and 532 nm, respectively, was used to measure EGFP-
specific fluorescence. The IgG concentration in the cul-
ture medium was determined by sandwich ELISA as
previously described [4].
Results
PB Transposition significantly enhances co-expression of
multiple genes from stable pools compared to standard
transfection
Cells were co-transfected with three artificial transpo-
sons namely, eGFP and the heavy and light chains of a
human IgG1 antibody along with the plasmid coding for
the transposase. Cell populations recovered after selec-
tion showed 30 % of GFP positive cells for standard
transfections, whereas for pools generated by PB trans-
position, the percentage of cells producing GFP was up
to 80%, which represent a 2.5 fold improvement (Fig.
1A). IgG1 productivity up to 120 mg/L was achieved
using transposition, whereas in standard transfections
* Correspondence: florian.wurm@epfl.ch
Laboratory for Cellular Biotechnology (LBTC), Faculty of Life Sciences, École
Polytechnique Fédérale de Lausanne CH-1015 Lausanne, Switzerland
Full list of author information is available at the end of the article
Balasubramanian et al. BMC Proceedings 2011, 5(Suppl 8):P32
http://www.biomedcentral.com/1753-6561/5/S8/P32
© 2011 Balasubramanian et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.the highest titers obtained were only 5 mg/L, corre-
sponding to a 24 fold improvement (Fig. 1B).
No significant differences were observed in the per-
centage of GFP positive cells and IgG productivity in
cell pools generated by transposition with 5 or 10 days
of selection. However, increased IgG productivity and %
GFP-positive cells were observed with 10 days of selec-
tion in case of standard transfection (data not shown).
This shows that a longer duration of selection pressure
is necessary to generate pools by standard transfections
compared to transposition. Furthermore, increased anti-
body productivity was observed with increasing puromy-
cin concentration (Fig. 1).
PB transposition strongly improved clonal productivity
Four different plasmids coding for (1) EGFP, (2)
mKATE, (3) the light and (4) heavy chain genes of a
human IgG1 antibody. Clones for both the standard and
the transposition-based transfections were generated by
limiting dilution of the cell pools after selection for 10
days. The IgG productivities of 65 clones of each stan-
dard transfection and transposition were analyzed.
About 96% of the clones generated by the standard
transfection were found to be low-producing. However,
more than 40% of clones generated by transposition
produced more than 20 mg/L and about 12% of the
clones were high-producers (Table 1).
Conclusions
Based on the above results we conclude that the piggy-
Bac transposon system provides an efficient method for
the co-integration of multiple genes. The use of the PB
transposon system for the co-integration of multiple
genes generates a higher frequency of high-producing
clones than standard transfection. The GFP-expressing
cell population was larger and the volumetric antibody
productivity of the pools were higher with higher strin-
gency of selection. A selection period with puromycin of
only 5 days was sufficient for the generation of pools
from transposon mediated transfection.
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Figure 1 Comparison of the A) %GFP positive cells and B) IgG1 productivity between pools generated using standard transfection (left) and PB
transposition (right)
Table 1 Distribution of clones based on their IgG
productivity
Productivity Range Standard Transfection Transposition
<20 mg/L 96% 57%
20-60 mg/L 4% 30%
>60 mg/L 0% 13%
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